Geode Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
|
|||||
|
2025
Q1 | $2.33M | Buy |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2024
Q3 | $2.71M | Sell |
|
|||||
|
2024
Q2 | $2.69M | Buy |
|
|||||
|
2024
Q1 | $2.77M | Buy |
|
|||||
|
2023
Q4 | $2.86M | Buy |
|
|||||
|
2023
Q3 | $1.91M | Buy |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $1.99M | Buy |
|
|||||
|
2022
Q4 | $2.18M | Sell |
|
|||||
|
2022
Q3 | $2.23M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $862K | Hold |
|
|||||
|
2021
Q4 | $880K | Buy |
|
|||||
|
2021
Q3 | $330K | Hold |
|
|||||
|
2021
Q2 | $403K | Buy |
|
|||||
|
2021
Q1 | $344K | Hold |
|
|||||
|
2020
Q4 | $295K | Hold |
|
|||||
|
2020
Q3 | $213K | Hold |
|
|||||
|
2020
Q2 | $241K | Hold |
|
|||||
|
2020
Q1 | $218K | Hold |
|
|||||
|
2019
Q4 | $252K | Hold |
|
|||||
|
2019
Q3 | $173K | Hold |
|
|||||
|
2019
Q2 | $189K | Buy |
|
|||||
|
2019
Q1 | $143K | Hold |
|
|||||
|
2018
Q4 | $88K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $41K | Buy |
|
|||||
|
2016
Q4 | $77K | Buy |
|